Android Apple

FDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung Cancer

By Yahoo! Finance   |   2 weeks ago
FDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung Cancer

FDA approved AstraZeneca's Imfinzi for limited-stage small cell lung cancer treatment based on ADRIATIC trial results, showing improved overall survival and disease progression. Imfinzi also approved for early-stage non-small cell lung cancer and muscle-invasive bladder cancer.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.